LicianPro

Lexeo Therapeutics, Inc. ·

LXEO 8-K 2026-09-29

Lexeo Therapeutics, Inc. (LXEO) 8-K dated 2026-09-29 — accession 0001193125-26-407555.

Lexeo Therapeutics, Inc. (LXEO) is a biotechnology company listed on US.

Lexeo Therapeutics, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-407555.

This 8-K covers: Acquisition or disposition (Item 2.01), Unregistered share sale (Item 3.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LXEO revenue for 2022-12-31 was $654.0K. Net income was $59.3M. LXEO currently screens at market cap $147.7M.

Not investment advice. The LXEO SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr